GlaxoSmithKline Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 600 | 0.000354% |
State or Government | 986,535 | 0.582% |
Institutions | 18,031,975 | 10.6% |
General Public | 23,332,400 | 13.8% |
Public Companies | 127,054,524 | 75% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
127,054,524 | ₹239.1b | 0% | no data | |||
3,869,950 | ₹7.3b | -22% | 0.06% | |||
2,157,098 | ₹4.1b | -47.5% | 0.09% | |||
2,115,160 | ₹4.0b | 0% | 1.59% | |||
1,924,817 | ₹3.6b | -42.7% | 0.23% | |||
1,751,731 | ₹3.3b | 116% | 0.12% | |||
1,151,961 | ₹2.2b | 0% | no data | |||
986,485 | ₹1.9b | -0.43% | no data | |||
860,000 | ₹1.6b | 115% | 0.31% | |||
813,149 | ₹1.5b | 0% | 0.02% | |||
737,893 | ₹1.4b | 16.7% | no data | |||
734,622 | ₹1.4b | 0% | 0.07% | |||
406,574 | ₹765.1m | 0% | 0.33% | |||
209,725 | ₹394.6m | -23% | no data | |||
190,391 | ₹358.3m | 26.3% | no data | |||
146,200 | ₹275.1m | -16.2% | 0.18% | |||
134,471 | ₹253.0m | 199% | 0.06% | |||
127,950 | ₹240.8m | 113% | 0.63% | |||
105,324 | ₹198.2m | 34.2% | 0.01% | |||
85,000 | ₹160.0m | 0% | 0.1% | |||
68,949 | ₹129.7m | 29.9% | no data | |||
57,236 | ₹107.7m | 0% | no data | |||
49,104 | ₹92.4m | 0% | no data | |||
42,636 | ₹80.2m | 13.1% | 0.02% | |||
39,473 | ₹74.3m | 16.2% | no data |